Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report.

Rao, Mayank; Bhattacharjee, Meenakshi; Shepard, Scott; Hsu, Sigmund

Rao, Mayank; Bhattacharjee, Meenakshi; Shepard, Scott; Hsu, Sigmund.

Afiliação

Rao M; The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Bhattacharjee M; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Shepard S; Department of Neurosurgery, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Hsu S; The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Oncotarget ; 14: 438, 2023 May 10.

Article em En | MEDLINE | ID: mdl-37163235

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article